The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Omega Diagnostics up on CE-marking of Covid test

Thu, 30th Jul 2020 13:23

(Sharecast News) - Omega Diagnostics updated the market on the work of the UK Rapid Test Consortium in the development of a Covid-19 'Abc-19' lateral flow antibody test on Thursday, reporting that lead partner Abingdon Health has CE-marked the test for professional use.
The AIM-traded firm said that, to achieve self-testing accreditation, pre-approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) was required to perform self-test usability studies.

It said the planned study would be performed by Ulster University using around 2,000 volunteers and, once complete, would allow the consortium to seek final approval from the MHRA for self-test use.

In addition, the test would also be subject to further independent evaluation.

Omega said it was currently transferring the manufacturing process from Abingdon Health to its Alva facility, and expected to complete the work to prove equivalent performance and the capability to manufacture at scale by the end of August.

The company was planning to have an initial AbC-19 test production capacity in place in September to produce 100,000 tests per week, scaling up to 200,000 tests per week in October.

If demand through the consortium was to go above 200,000 tests per week, either from the UK government or from other third parties, Omega said it would allocate additional capacity to meet that demand as well.

"I am delighted that our consortium partner Abingdon Health has delivered another key milestone as promised and it is even more impressive that this has been achieved within such a compressed timeline to meet very stringent technical requirements set by the MHRA," said chief executive officer Colin King.

"Omega is focused on ensuring it completes the technical transfer in a timely manner and plays its part in the fight against this pandemic."

At 1105 BST, shares in Omega Diagnostics Group were up 3.2% at 62.95p.
More News
13 Feb 2014 10:26

STOCKS NEWS EUROPE-UK small caps lag AIM-listed shares

Junior-listed AIM shares rise 0.3 percent, outperforming the FTSE Small Cap index, down 0.3 percent, the mid-caps, down 0.7 percent, and the blue chips, which fall 0.6 percent. Troubled Czech coalminer New World Resources drops 6.9 percent, the top small cap faller, after posting a record 4

Read more
13 Feb 2014 09:24

Omega Diagnostics Completes CD4 Technology Transfer Project

LONDON (Alliance News) - Omega Diagnostics Group PLC said Thursday that it had completed its CD4 technology transfer project, having successfully completed a three-batch validation of its manufacturing protocol. The medical diagnostics company has been undertaking a number of experiments to

Read more
27 Nov 2013 11:26

Omega Diagnostics Confident For Next Year But Cautious On This One

Read more
27 Nov 2013 09:39

STOCKS NEWS EUROPE-UK small caps rise, lagging blue-chips

The FTSE Small Caps Index edges up by 0.2 percent in early session trading, slightly lagging a 0.4 percent advance on the blue-chip FTSE 100 index and underperforming a 0.6 percent rise on the FTSE 250 mid-caps index . The junior-listed FTSE AIM All Share Index slips 0.1 percent. Paw

Read more
27 Nov 2013 07:57

AIM IN BRIEF: Albemarle & Bond Sees No Signs Of Recovery

Read more
31 Oct 2013 14:21

Omega Diagnostics Expects To Complete CD4 Technology Transfer By End December

Read more
17 Oct 2013 09:11

Omega Diagnostics Expects Full-Year Revenues Of GBP5.6 Million

Read more
1 Jul 2013 07:53

Omega hurt by weak UK, European markets

Medical diagnostics firm Omega said full year profit tumbled 22 per cent following a slowdown in growth in European markets. Adjusted profit before tax fell to £0.78m in the year to the end of March from £1.0m in 2012. Annual turnover was little changed at £11.3m compared to £11.1m previously. Gr

Read more
24 May 2013 09:21

Omega Diagnostics raises funds for research and development

Medical company Omega Diagnostics Group has raised four million pounds through the placement of over 23m shares which will be used to fund the development of new products. The company, focused on developing diagnostics for allergies, food intolerances and infectious diseases, said it intends to use

Read more
19 Nov 2012 15:04

Omega Diagnostics awarded grant for HIV test

Omega Diagnostics has been awarded a grant of up to 150,000 pounds from Scottish Enterprise to help scale up manufacturing facilities for the company's new CD4 test for monitoring HIV positive patients. The facility will be located at the company's headquarters in Alva, Central Scotland and the gr

Read more
2 Jul 2012 16:42

Omega Diagnostics unveils strong year

Medical diagnostics group Omega Diagnostics posted a strong set of full year results which saw turnover rise 41 per cent and gross profit leap 49 per cent. Pre-tax profits came in at £0.48m (2011: £0.12m) on revenues of £11.1m, compared with £7.9m the previous year. Earning per share rose from 0.1

Read more
16 Apr 2012 10:58

Small caps round-up: Omega Diagnostics, Oxford Biomedica, i-design ...

The cash-point marketing company i-design said that revenues for the first half of its current financial year will be ahead of the same period of 2011. The group creates advertising solutions for banks and third parties through cash-point screens. A new contract with a Canadian bank has boosted turn

Read more
26 Nov 2010 15:49

Omega Diagnostics grows profit by 53%

Omega Diagnostics has pushed up its interim profit and there will be more to come when it completes the acquisition of a Germany-based allergy testing business. Revenues grew from £2.87m to £3.3m in the six months to September 2010, while underlying profit jumped from £263,000 to £403,000. That pro

Read more
17 Nov 2010 14:31

Small caps round-up: Judges Scientific, Media Corp, Omeda Diagnostics...

Scientific instruments designer Judges Scientific revealed that trading has continued to be "favourable" and adjusted earnings in respect of 2010 are likely to exceed current market expectations. Additionally, gas purifier and calibration equipment provider Sircal Instruments, acquired in March, has

Read more
13 Oct 2010 15:17

Small caps round-up: Tri-Star

Mining company Tri-Star has entered into an agreement with a Turkish contractor to undertake a 17-hole diamond drilling programme of the company's Goynuk antimony mine. Shares in Omega Diagnostics, which specialises in the diagnosis of diseases such as syphilis and TB, soared 16% after it reporte

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.